Literature DB >> 24175178

Platelets: A possible glance into brain biological processes in schizophrenia.

Eyal Asor1, Dorit Ben-Shachar.   

Abstract

Schizophrenia is a severe mental disorder, characterized by behavioral, emotional and cognitive disturbances, which commonly follows a chronic course. Diagnostic accuracy, management plans, treatment evaluation and prognosis are dependent on relatively subjective assessments. Despite extensive research and improvement in imaging technology, as well as modern genetic and molecular methodologies, the biological basis of this disease is still unclear. Therefore, there is a need for objective and valid biological markers. Platelets have often been used as a model in neurobiological research. The accessibility of platelets and their similarities with neurons turns them into an attractive candidate to search for biological markers for diagnosis and for unraveling pathophysiological processes relevant to the etiology of brain disorders, including schizophrenia. The present review addresses the main changes in platelet physiology observed in schizophrenia and its response to antipsychotic medication. We summarize numerous studies demonstrating impaired metabolism, uptake and receptor kinetics of schizophrenia-relevant neurotransmitters, abnormalities in membrane derived phospholipids and polyunsaturated fatty acids, as well as dysfunctions in the mitochondria. These changes fit with the various hypotheses raised for the etiology of schizophrenia, including the dopamine-glutamate hypothesis, the autoimmune hypothesis, the polyunsaturated fatty acid hypothesis and the impaired energy metabolism hypothesis. Despite extensive research in platelets, no conclusive reliable biomarker has been identified yet. This review suggests that the clinical heterogeneity and the biological complexity of schizophrenia lead to the inevitable conclusion that biomarkers will be identified only for subgroups characterized according to the different diagnostic criteria. Moreover, any biomarker would have to be an array of interrelated factors or even a set of several such arrays.

Entities:  

Keywords:  Biomarkers; Platelets; Schizophrenia

Year:  2012        PMID: 24175178      PMCID: PMC3782191          DOI: 10.5498/wjp.v2.i6.124

Source DB:  PubMed          Journal:  World J Psychiatry        ISSN: 2220-3206


  111 in total

1.  Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.

Authors:  D L Murphy; R J Wyatt
Journal:  Nature       Date:  1972-07-28       Impact factor: 49.962

Review 2.  Platelet research in psychiatry.

Authors:  A Wirz-Justice
Journal:  Experientia       Date:  1988-02-15

3.  Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder.

Authors:  J E Downhill; M S Buchsbaum; T Wei; J Spiegel-Cohen; E A Hazlett; M M Haznedar; J Silverman; L J Siever
Journal:  Schizophr Res       Date:  2000-05-05       Impact factor: 4.939

4.  Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia.

Authors:  M Jakovljević; D Mück-Seler; N Pivac; D Ljubicić; M Bujas; G Dodig
Journal:  Biol Psychiatry       Date:  1997-05-15       Impact factor: 13.382

Review 5.  Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment.

Authors:  C G Gottfries
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

6.  Increased platelet phospholipase A2 activity in schizophrenia.

Authors:  W F Gattaz; A Schmitt; A Maras
Journal:  Schizophr Res       Date:  1995-07       Impact factor: 4.939

7.  Platelet serotonin levels in schizophrenia: relationship to race and psychopathology.

Authors:  H Jackman; D Luchins; H Y Meltzer
Journal:  Biol Psychiatry       Date:  1983-08       Impact factor: 13.382

8.  Relationship of auditory hallucinations and paranoia to platelet MAO activity in schizophrenics: sex and race interactions.

Authors:  H Y Meltzer; J L Zureick
Journal:  Psychiatry Res       Date:  1987-10       Impact factor: 3.222

9.  Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.

Authors:  Nadia R Barbosa; Ricardo M Junqueira; Homero P Vallada; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

10.  Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients.

Authors:  Belén Arranz; Pilar Rosel; Salvador Sarró; Nicolás Ramirez; Rosa Dueñas; Ramón Cano; José María Sanchez; Luis San
Journal:  Psychiatry Res       Date:  2003-05-30       Impact factor: 3.222

View more
  12 in total

1.  Does patchouli oil change blood platelet monoamine oxidase-A activity of adult mammals?

Authors:  Md Fazlul Karim; Soumyabrata Banerjee; Mrinal K Poddar
Journal:  J Physiol Sci       Date:  2017-04-01       Impact factor: 2.781

2.  Known and Unexplored Post-Translational Modification Pathways in Schizophrenia.

Authors:  Bradley J Smith; Victor C Carregari
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

3.  Reduced Platelet MAO-B Activity Is Associated with Psychotic, Positive, and Depressive Symptoms in PTSD.

Authors:  Senka Repovecki; Gordana Nedic Erjavec; Suzana Uzun; Lucija Tudor; Matea Nikolac Perkovic; Marcela Konjevod; Oliver Kozumplik; Dubravka Svob Strac; Zrnka Kovacic Petrovic; Ninoslav Mimica; Nela Pivac
Journal:  Biomolecules       Date:  2022-05-23

4.  Platelets in psychiatric disorders.

Authors:  Daniela Ehrlich; Christian Humpel
Journal:  World J Psychiatry       Date:  2012-12-22

5.  Neuropsychological correlates of remission in chronic schizophrenia subjects: The role of general and task-specific executive processes.

Authors:  Thais Rabanea-Souza; Henrique T Akiba; Arthur A Berberian; Rodrigo A Bressan; Álvaro M Dias; Acioly L T Lacerda
Journal:  Schizophr Res Cogn       Date:  2016-02-16

6.  A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in platelets.

Authors:  Manisha Padmakumar; Jaak Jaeken; Vincent Ramaekers; Lieven Lagae; Daniel Greene; Chantal Thys; Chris Van Geet; Nihr BioResource; Kathleen Stirrups; Kate Downes; Ernest Turro; Kathleen Freson
Journal:  JIMD Rep       Date:  2019-03-25

Review 7.  Beyond Haemostasis and Thrombosis: Platelets in Depression and Its Co-Morbidities.

Authors:  Benedetta Izzi; Alfonsina Tirozzi; Chiara Cerletti; Maria Benedetta Donati; Giovanni de Gaetano; Marc F Hoylaerts; Licia Iacoviello; Alessandro Gialluisi
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

8.  Platelet studies in autism spectrum disorder patients and first-degree relatives.

Authors:  Nora Bijl; Chantal Thys; Christine Wittevrongel; Wouter De la Marche; Koenraad Devriendt; Hilde Peeters; Chris Van Geet; Kathleen Freson
Journal:  Mol Autism       Date:  2015-10-23       Impact factor: 7.509

Review 9.  Blood platelet research in autism spectrum disorders: In search of biomarkers.

Authors:  Manisha Padmakumar; Eveline Van Raes; Chris Van Geet; Kathleen Freson
Journal:  Res Pract Thromb Haemost       Date:  2019-07-16

10.  Detention in Juvenile Correctional Facilities Is Associated with Higher Platelet Monoamine Oxidase B Activity in Males.

Authors:  Josip Podobnik; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Katarina Dodig Curkovic; Mario Curkovic; Vlatka Kovac; Dubravka Svob Strac; Melita Cusek; Marco Bortolato; Nela Pivac
Journal:  Biomolecules       Date:  2020-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.